However, elevations in IFN levels and especially the use of recombinant IFN-alpha may have a therapeutic role in BD, although the mechanism of action of IFN-alpha in BD is not fully understood and there may be pathogenic heterogeneity. Here, IFNA1 is linked to Behcet disease.